These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4130309)

  • 1. Alginate-antacid in the reduction of gastro-oesophageal reflux.
    Stanciu C; Bennett JR
    Lancet; 1974 Jan; 1(7848):109-11. PubMed ID: 4130309
    [No Abstract]   [Full Text] [Related]  

  • 2. Review article: alginate-raft formulations in the treatment of heartburn and acid reflux.
    Mandel KG; Daggy BP; Brodie DA; Jacoby HI
    Aliment Pharmacol Ther; 2000 Jun; 14(6):669-90. PubMed ID: 10848650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of sodium alginate (Gaviscon) for the treatment of gastro-oesophageal reflux in preterm infants.
    Corvaglia L; Aceti A; Mariani E; De Giorgi M; Capretti MG; Faldella G
    Aliment Pharmacol Ther; 2011 Feb; 33(4):466-70. PubMed ID: 21158879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and laboratory studies of the antacid and raft-forming properties of Rennie alginate suspension.
    Tytgat GN; Simoneau G
    Aliment Pharmacol Ther; 2006 Mar; 23(6):759-65. PubMed ID: 16556178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-prandial reflux suppression by a raft-forming alginate (Gaviscon Advance) compared to a simple antacid documented by magnetic resonance imaging and pH-impedance monitoring: mechanistic assessment in healthy volunteers and randomised, controlled, double-blind study in reflux patients.
    Sweis R; Kaufman E; Anggiansah A; Wong T; Dettmar P; Fried M; Schwizer W; Avvari RK; Pal A; Fox M
    Aliment Pharmacol Ther; 2013 Jun; 37(11):1093-102. PubMed ID: 23600790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket-targeting alginate-antacid (Gaviscon Double Action) - a double-blind, placebo-controlled, pilot study in gastro-oesophageal reflux disease.
    Thomas E; Wade A; Crawford G; Jenner B; Levinson N; Wilkinson J
    Aliment Pharmacol Ther; 2014 Mar; 39(6):595-602. PubMed ID: 24471505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastro-oesophageal pH measurements during reflux induced by provocative tests.
    Baldi F; Longanesi A; Ferrarini F; Ragazzini M; Michieletti G
    Br J Clin Pract Suppl; 1989 Feb; 66():10-4; discussion 35-6. PubMed ID: 2511916
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of moderate to severe gastro-oesophageal reflux with an alginate/antacid combination.
    Hasan SS
    Curr Med Res Opin; 1980; 6(10):645-8. PubMed ID: 7428400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alginate-raft preparations in the treatment of acid reflux and heartburn (literature review)].
    Mandel KG; Deggi BP; Brodi DA; Jeykobi GI
    Eksp Klin Gastroenterol; 2008; (4):64-77. PubMed ID: 19145905
    [No Abstract]   [Full Text] [Related]  

  • 10. [Can acid pocket-targeting alginate-antacid (Gaviscon Double Action) relieve upper gastrointestinal symptoms in gastro-oesophageal reflux disease?].
    Kim SE; Park MI
    Korean J Gastroenterol; 2014 Jun; 63(6):386-8. PubMed ID: 25097964
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of gastroesophageal reflux with an original preparation containing alginate/antacid or pectinate/antacid].
    Stanciu C; Bălan G; Cijevschi C; Sănduiescu E; Frasin M; Filimon L; Ariton S; Busuioc I; Taraşi G
    Rev Med Chir Soc Med Nat Iasi; 1985; 89(2):233-6. PubMed ID: 4089324
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomised clinical trial: the clinical efficacy and safety of an alginate-antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China.
    Sun J; Yang C; Zhao H; Zheng P; Wilkinson J; Ng B; Yuan Y
    Aliment Pharmacol Ther; 2015 Oct; 42(7):845-54. PubMed ID: 26228097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Estimation of efficiency of alginate-raft barrier in treatment of gastroesophageal reflux disease].
    Bordin DS; Masharova AA; Firsova LD; Kozhurina TS; Safonova OV
    Eksp Klin Gastroenterol; 2008; (6):77-81. PubMed ID: 19334430
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid onset of effect of sodium alginate on gastro-oesophageal reflux compared with ranitidine and omeprazole, and relationship between symptoms and reflux episodes.
    Dettmar PW; Sykes J; Little SL; Bryan J
    Int J Clin Pract; 2006 Mar; 60(3):275-83. PubMed ID: 16494641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of heartburn symptoms to a new cimetidine/alginate combination compared with an alginic acid/antacid.
    Lennox B; Snell C; Lamb Y
    Br J Clin Pract; 1988 Dec; 42(12):503-5. PubMed ID: 3076786
    [No Abstract]   [Full Text] [Related]  

  • 16. Measurement of gastro-oesophageal reflux after antacid administration using a perfusion technique.
    Frommer DJ
    Curr Med Res Opin; 1981; 7(7):452-7. PubMed ID: 7261662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical treatment of symptomatic hiatus hernia with low-density compounds.
    Beeley M; Warner JO
    Curr Med Res Opin; 1972; 1(2):63-9. PubMed ID: 4589019
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of alginate-based reflux suppressant and magnesium-aluminium antacid gel for treatment of heartburn in pregnancy: a randomized double-blind controlled trial.
    Meteerattanapipat P; Phupong V
    Sci Rep; 2017 Mar; 7():44830. PubMed ID: 28317885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An alginate-antacid formulation (Gaviscon Double Action Liquid) can eliminate or displace the postprandial 'acid pocket' in symptomatic GERD patients.
    Kwiatek MA; Roman S; Fareeduddin A; Pandolfino JE; Kahrilas PJ
    Aliment Pharmacol Ther; 2011 Jul; 34(1):59-66. PubMed ID: 21535446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized clinical trial: a double-blind, placebo-controlled study to assess the clinical efficacy and safety of alginate-antacid (Gaviscon Double Action) chewable tablets in patients with gastro-oesophageal reflux disease.
    Wilkinson J; Wade A; Thomas SJ; Jenner B; Hodgkinson V; Coyle C
    Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):86-93. PubMed ID: 30272584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.